T. Korbut

发表

The Vascular Disrupting Agent STA-9584 Exhibits Potent Antitumor Activity by Selectively Targeting Microvasculature at Both the Center and Periphery of Tumors

K. Foley, Jun-xia Jiang, Jim Sang, 2012, Journal of Pharmacology and Experimental Therapeutics.

Mitochondrial Involvement : Evidence for 2 ( Rh-123 ) 4 Lines Are Collaterally Sensitive to PtCl-Diamminedichloroplatinum ( II ) Resistant Human Tumor Cell cis

B. Teicher, T. Kusumoto, Timothy, 2006 .

Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.

B. Teicher, T. Herman, L. Ayash, 1991, Cancer letters.

Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)

B. Teicher, T. Herman, S. Holden, 1991, International journal of cancer.

Cytotoxicity of antitumor platinum complexes withl-buthionine-(R, S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin

B. Teicher, S. Holden, T. Korbut, 2004, Cancer Chemotherapy and Pharmacology.

Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine

B. Teicher, T. Herman, J. Eder, 1993, Cancer Chemotherapy and Pharmacology.

Interaction of topoisomerase I inhibitors with radiation in cis‐diamminedichloroplatinum(II)‐sensitive and ‐resistantcells In Vitro and in the fsaiic fibrosarcoma In Vivo

B. Teicher, G. Ara, S. Holden, 1993, International journal of cancer.

Syntheses and antitumor activities of N'1,N'3-dialkyl-N'1,N'3-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol.

J. Wu, Lijun Sun, Shoujun Chen, 2013, Bioorganic & medicinal chemistry letters.

CAI: effects on cytotoxic therapies in vitro and in vivo

B. Teicher, G. Ara, S. Holden, 2004, Cancer Chemotherapy and Pharmacology.

Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.

B. Teicher, T. Herman, T. Korbut, 1990, Cancer research.

Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.

B. Teicher, T. Herman, K. Menon, 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies

B. Teicher, G. Ara, S. Holden, 2004, Cancer Chemotherapy and Pharmacology.

Combinationof A^A^A^'-Triethylenethiophosphoramide and Cyclophosphamide i/i Vitro and in Vivo1

B. Teicher, E. Frei, S. Holden, 1988 .

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

B. Teicher, G. Ara, S. Holden, 1996, Cancer Chemotherapy and Pharmacology.

Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling

D. Proia, K. Foley, R. Bates, 2011, PloS one.

Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.

B. Teicher, E. Frei, S. Holden, 1988, Cancer research.

Synergism between photochemical and ionizing radiation effects in MCF-7 cells in vitro

Gulshan Ara, Terence S. Herman, Archana Varshney, 1992, Photonics West - Lasers and Applications in Science and Engineering.

cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.

B. Teicher, T. Kusumoto, G. Ara, 1994, Cancer research.

Syntheses and antitumor activities of N'1,N'3-dialkyl-N'1,N'3-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol.

Lijun Sun, Jim Z Wu, Shoujun Chen, 2013, Bioorganic & Medicinal Chemistry Letters.